This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gum, R. J. Articles by Ulrich, R. G. Search for Related Content PubMed PubMed Citation Articles by Gum, R. J. Articles by Ulrich, R. G.

Antisense Protein Tyrosine Phosphatase 1B Reverses Activation of p38 Mitogen-Activated Protein Kinase in Liver of ob/ob Mice

Abbott Laboratories, Abbott Park, Illinois 60064

Address all correspondence and requests for reprints to: Rebecca J. Gum, Abbott Laboratories, Department R-4CK, AP10-1, 100 Abbott Park Road, Abbott Park, Illinois 60064-3502. E-mail: rebecca.gum{at}abbott.com.

Phosphorylation of stress-activated kinase p38, a MAPK family member, was increased in liver of ob/ob diabetic mice relative to lean littermates. Treatment of ob/ob mice with protein tyrosine phosphatase 1B (PTP1B) antisense oligonucleotides (ASO) reduced phosphorylation of p38 in liver—to below lean littermate levels—and normalized plasma glucose while reducing plasma insulin. Phosphorylation of ERK, but not JNK, was also decreased in ASO-treated mice. PTP1B ASO decreased TNF protein levels and phosphorylation of the transcription factor cAMP response element binding protein (CREB) in liver, both of which can occur through decreased phosphorylation of p38 and both of which have been implicated in insulin resistance or hyperglycemia. Decreased p38 phosphorylation was not directly due to decreased phosphorylation of the kinases that normally phosphorylate p38—MKK3 and MKK6. Additionally, p38 phosphorylation was not enhanced in liver upon insulin stimulation of ASO-treated ob/ob mice (despite increased activation of other signaling molecules) corroborating that p38 is not directly affected via the insulin receptor. Instead, decreased phosphorylation of p38 may be due to increased expression of MAPK phosphatases, particularly the p38/ERK phosphatase PAC1 (phosphatase of activated cells). This study demonstrates that reduction of PTP1B protein using ASO reduces activation of p38 and its substrates TNF and CREB in liver of diabetic mice, which correlates with decreased hyperglycemia and hyperinsulinemia.

This article has been cited by other articles:

				B. Emanuelli, D. Eberle, R. Suzuki, and C. R. Kahn Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance PNAS, March 4, 2008; 105(9): 3545 - 3550. [Abstract] [Full Text] [PDF]

				B. Xue, Y.-B. Kim, A. Lee, E. Toschi, S. Bonner-Weir, C. R. Kahn, B. G. Neel, and B. B. Kahn Protein-tyrosine Phosphatase 1B Deficiency Reduces Insulin Resistance and the Diabetic Phenotype in Mice with Polygenic Insulin Resistance J. Biol. Chem., August 17, 2007; 282(33): 23829 - 23840. [Abstract] [Full Text] [PDF]

				Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes J. Biol. Chem., August 25, 2006; 281(34): 24336 - 24344. [Abstract] [Full Text] [PDF]

				L. Qiao, O. A. MacDougald, and J. Shao CCAAT/Enhancer-binding Protein {alpha} Mediates Induction of Hepatic Phosphoenolpyruvate Carboxykinase by p38 Mitogen-activated Protein Kinase J. Biol. Chem., August 25, 2006; 281(34): 24390 - 24397. [Abstract] [Full Text] [PDF]

				L. M. Federico, M. Naples, D. Taylor, and K. Adeli Intestinal Insulin Resistance and Aberrant Production of Apolipoprotein B48 Lipoproteins in an Animal Model of Insulin Resistance and Metabolic Dyslipidemia: Evidence for Activation of Protein Tyrosine Phosphatase-1B, Extracellular Signal-Related Kinase, and Sterol Regulatory Element-Binding Protein-1c in the Fructose-Fed Hamster Intestine. Diabetes, May 1, 2006; 55(5): 1316 - 1326. [Abstract] [Full Text] [PDF]

				O. Kaidanovich-Beilin and H. Eldar-Finkelman Long-Term Treatment with Novel Glycogen Synthase Kinase-3 Inhibitor Improves Glucose Homeostasis in ob/ob Mice: Molecular Characterization in Liver and Muscle J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 17 - 24. [Abstract] [Full Text] [PDF]

				E. M. Allister, N. M. Borradaile, J. Y. Edwards, and M. W. Huff Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes Diabetes, June 1, 2005; 54(6): 1676 - 1683. [Abstract] [Full Text] [PDF]

				F. G. Haj, J. M. Zabolotny, Y.-B. Kim, B. B. Kahn, and B. G. Neel Liver-specific Protein-tyrosine Phosphatase 1B (PTP1B) Re-expression Alters Glucose Homeostasis of PTP1B-/-Mice J. Biol. Chem., April 15, 2005; 280(15): 15038 - 15046. [Abstract] [Full Text] [PDF]

				J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action J. Biol. Chem., June 4, 2004; 279(23): 24844 - 24851. [Abstract] [Full Text] [PDF]

				D. Melloul and M. Stoffel Regulation of Transcriptional Coactivator PGC-1{alpha} Sci. Aging Knowl. Environ., March 3, 2004; 2004(9): pe9 - 9. [Abstract] [Full Text]